Micropos Medical Announces Initial Clinical Treatments at Johns Hopkins Medicine Using Raypilot System

Micropos Medical reported that the first five U.S. patients have been treated with its Raypilot® System at Johns Hopkins Medicine as part of an early clinical evaluation. The update is an early-stage clinical milestone, which is modestly positive but unlikely to materially move markets absent efficacy/safety results.

Analysis

Micropos Medical reported that the first five U.S. patients have been treated with its Raypilot® System at Johns Hopkins Medicine as part of an early clinical evaluation. The update is an early-stage clinical milestone, which is modestly positive but unlikely to materially move markets absent efficacy/safety results.